While the other functionally complementary scaffolding factors eIF4E and eIF4GI have been described as significantly increased in a variety of cancers [8]–[10], [17]–[19], our studies are the first to implicate eIF4GII in a malignancy. This evidence concerns the gene EIF4G3 and cancer.